Association of the tumour necrosis factor α -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis

被引:76
作者
Mitchell, SA
Grove, J
Spurkland, A
Boberg, KM
Fleming, KA
Day, CP
Schrumpf, E
Chapman, RW [1 ]
机构
[1] Oxford Radcliffe Hosp, Dept Gastroenterol, Oxford, England
[2] Univ Oxford, Nuffield Dept Pathol & Bacteriol, Oxford, England
[3] Univ Newcastle, Liver Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
[4] Natl Hosp, Inst Transplant Immunol, Oslo, Norway
[5] Univ Oslo, Natl Hosp, Dept Med, Oslo, Norway
关键词
D O I
10.1136/gut.49.2.288
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology. Abnormalities in immune regulation and genetic associations suggest that PSC is an immune mediated disease. Several polymorphisms within the tumour necrosis factor a (TNF-alpha) and interleukin 10 (IL-10) promoter genes have been described which influence expression of these cytokines. This study examines the possible association between polymorphisms at the -308 and -627 positions in the TNF-alpha and IL-10 promoter genes, respectively, and susceptibility to PSC. Methods - TNF-alpha -308 genotypes were studied by polymerase chain reaction (PCR) in 160 PSC patients from Norway and the UK compared with 145 ethnically matched controls. IL-10 -627 genotypes were studied by FCR in 90 PSC patients compared with 84 ethnically matched controls. Results - A total of 16% of Norwegian PSC patients and 12% of British PSC patients were homozygous for the TNF2 allele compared with 3% and 6% of respective controls. The TNF2 allele was present in 60% of PSC patients versus 30% of controls (ORcombined data = 3.2 (95% confidence intervals (CI) 1.8-4.5); p(corr) = 10(-5)). The association between the TNF2 allele and susceptibility to PSC was independent of the presence of concurrent inflammatory bowel disease (IBD) in the PSC patients; 61% of PSC patients without IBD had TNF2 compared with 30% of controls (ORcombined data = 3.2 (95% CI 1.2-9.0); p(corr) = 0.006). There was no difference in the -627 IL-10 polymorphism distributions between patients and controls in either population. The increase in TNF2 allele in PSC patients only occurs in the presence of DRB1*0301 (DR3) and B8. In the combined population data, DRB1*0301 showed a stronger association with susceptibility to PSC than both the TNF2 and B8 alleles (ORcombined data = 3.8, p(corr) = 10(-6) v O-Rcombined data = 3.2) p(corr) = 10(-5) v ORcombined data = 3.41, p(corr) = 10(-4), respectively). Conclusions - This study identified a significant association between possession of the TNF2 allele, a G -->A substitution at position -308 in the TNF-a promoter, and susceptibility to PSC. This association was secondary to the association of PSC with the A1-E8-DRB1*0301-DQA1*0501-DQB1*0201 haplotype. No association was found between the IL-10 -627 promoter polymorphism and PSC.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 40 条
  • [1] Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis
    Bernal, W
    Moloney, M
    Underhill, J
    Donaldson, PT
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (02) : 237 - 241
  • [2] Interleukin-10 regulation in normal subjects and patients with asthma
    Borish, L
    Aarons, A
    Rumbyrt, J
    Cvietusa, P
    Negri, J
    Wenzel, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (06) : 1288 - 1296
  • [3] Genetic markers in clinically well defined patients with ulcerative colitis (UC)
    Bouma, G
    Crusius, JBA
    García-González, MA
    Meijer, BUGA
    Hellemans, HPR
    Hakvoort, RJ
    Schreuder, GMT
    Kostense, PJ
    Meuwissen, SGM
    Peña, AS
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 115 (02) : 294 - 300
  • [4] Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in Multiple Sclerosis and it's influence on the regulation of TNF-alpha production
    Braun, N
    Michel, U
    Ernst, BP
    Metzner, R
    Bitsch, A
    Weber, F
    Rieckmann, P
    [J]. NEUROSCIENCE LETTERS, 1996, 215 (02) : 75 - 78
  • [5] Brinkman B M, 1995, J Inflamm, V46, P32
  • [6] PRIMARY SCLEROSING CHOLANGITIS - A REVIEW OF ITS CLINICAL-FEATURES, CHOLANGIOGRAPHY, AND HEPATIC HISTOLOGY
    CHAPMAN, RWG
    ARBORGH, BAM
    RHODES, JM
    SUMMERFIELD, JA
    DICK, R
    SCHEUER, PJ
    SHERLOCK, S
    [J]. GUT, 1980, 21 (10) : 870 - 877
  • [7] INCREASED FREQUENCY OF THE UNCOMMON ALLELE OF A TUMOR-NECROSIS-FACTOR-ALPHA GENE POLYMORPHISM IN RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    DANIS, VA
    MILLINGTON, M
    HYLAND, V
    LAWFORD, R
    HUANG, QR
    GRENNAN, D
    [J]. DISEASE MARKERS, 1995, 12 (02) : 127 - 133
  • [8] DONALDSON PT, 1998, PRIMARY SCLEROSING C, P22
  • [9] AMINO-ACID SUBSTITUTIONS AT POSITION-38 OF THE DR-BETA POLYPEPTIDE CONFER SUSCEPTIBILITY TO AND PROTECTION FROM PRIMARY SCLEROSING CHOLANGITIS
    FARRANT, JM
    DOHERTY, DG
    DONALDSON, PT
    VAUGHAN, RW
    HAYLLAR, KM
    WELSH, KI
    EDDLESTON, ALWF
    WILLIAMS, R
    [J]. HEPATOLOGY, 1992, 16 (02) : 390 - 395
  • [10] EVIDENCE THAT THE T-CELL REPERTOIRE OF NORMAL RATS CONTAINS CELLS WITH THE POTENTIAL TO CAUSE DIABETES - CHARACTERIZATION OF THE CD4+ T-CELL SUBSET THAT INHIBITS THIS AUTOIMMUNE POTENTIAL
    FOWELL, D
    MASON, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) : 627 - 636